{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:27:27Z","timestamp":1789763247521,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03013-8","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:01:52Z","timestamp":1757408512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pterostilbene as a promising natural anticancer agent in gynecological cancers"],"prefix":"10.1007","volume":"42","author":[{"given":"Tayyeba","family":"Rehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhiya","family":"Amen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"3013_CR1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/JS9.0000000000001956","volume":"111","author":"Y Liang","year":"2025","unstructured":"Liang Y, Dai X, Chen J, Zeng X, Qing X, Huang J, et al. Global burden and trends in pre- and post-menopausal gynecological cancer from 1990 to 2019, with projections to 2040: a cross-sectional study. Int J Surg. 2025;111:891\u2013903.","journal-title":"Int J Surg"},{"key":"3013_CR2","doi-asserted-by":"crossref","unstructured":"Li M, Xu S, Yang Q, Zheng Z, Zhang X, Liu H, et al. Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031. Int J Gynecol Obstet. 2025.","DOI":"10.1002\/ijgo.70351"},{"key":"3013_CR3","volume":"6","author":"Z Momenimovahed","year":"2023","unstructured":"Momenimovahed Z, Mazidimoradi A, Maroofi P, Allahqoli L, Salehiniya H, Alkatout I. Global, regional and national burden, incidence, and mortality of cervical cancer. Cancer Rep. 2023;6: e1756.","journal-title":"Cancer Rep"},{"key":"3013_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_351294","author":"FG Bejar","year":"2022","unstructured":"Bejar FG, Oaknin A, Williamson C, Mayadev J, Peters PN, Secord AA, et al. Novel therapies in gynecologic cancer. Am Soc Clin Oncol Educ Book. 2022. https:\/\/doi.org\/10.1200\/EDBK_351294.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"3013_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.31531\/2581-4745.1000152","volume":"7","author":"A Majumder","year":"2024","unstructured":"Majumder A, Ghorui S, Sengupta S, Bhattacharya M. Identification of potential inhibitors of PTEN tumor suppressor gene from phytochemical constituents found in tomato (Solanum lycopersicum) via biocomputational analysis. Int J Biomed Investig. 2024;7:19\u201331.","journal-title":"Int J Biomed Investig"},{"issue":"19","key":"3013_CR6","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.3390\/molecules27196316","volume":"27","author":"S Nagarajan","year":"2022","unstructured":"Nagarajan S, Mohandas S, Ganesan K, Xu B, Ramkumar KM. New insights into dietary pterostilbene: sources, metabolism, and health promotion effects. Molecules. 2022;27(19):6316.","journal-title":"Molecules"},{"issue":"15","key":"3013_CR7","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1021\/jf040095e","volume":"52","author":"AM Rimando","year":"2004","unstructured":"Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J Agric Food Chem. 2004;52(15):4713\u20139.","journal-title":"J Agric Food Chem"},{"issue":"21","key":"3013_CR8","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.3390\/molecules25215166","volume":"25","author":"Y Liu","year":"2020","unstructured":"Liu Y, You Y, Lu J, Chen X, Yang Z. Recent advances in synthesis, bioactivity, and pharmacokinetics of Pterostilbene, an important analog of resveratrol. Molecules. 2020;25(21):5166.","journal-title":"Molecules"},{"key":"3013_CR9","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/abfdec","volume":"32","author":"Y Zou","year":"2021","unstructured":"Zou Y, Wang X, Bi D, Fu J, Han J, Guo Y, et al. Pterostilbene nanoparticles with small particle size show excellent anti-breast cancer activity in vitro and in vivo. Nanotechnology. 2021;32: 32.","journal-title":"Nanotechnology"},{"issue":"4","key":"3013_CR10","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1208\/s12249-014-0129-4","volume":"15","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Shang Z, Gao C, Du M, Xu S, Song H, et al. Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. AAPS PharmSciTech. 2014;15(4):1000\u20138.","journal-title":"AAPS PharmSciTech"},{"key":"3013_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/463595","volume":"2013","author":"DM Riche","year":"2013","unstructured":"Riche DM, McEwen CL, Riche KD, Sherman JJ, Wofford MR, Deschamp D, et al. Analysis of safety from a human clinical trial with pterostilbene. J Toxicol. 2013;2013: 463595.","journal-title":"J Toxicol"},{"key":"3013_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/459165","volume":"2014","author":"DM Riche","year":"2014","unstructured":"Riche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, et al. Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial. Evidence Based Complement Altern Med. 2014;2014: 459165.","journal-title":"Evidence Based Complement Altern Med"},{"key":"3013_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-025-02721-5","volume":"42","author":"MA Ali","year":"2025","unstructured":"Ali MA, Kaleem N, Ali A, Khan N, Khaliq M, Arif N, et al. Pterostilbene as a multifaceted anticancer agent: molecular mechanisms, therapeutic potential and future directions. Med Oncol. 2025;42:1\u201322.","journal-title":"Med Oncol"},{"issue":"12","key":"3013_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14715\/10.14715\/cmb\/2017.63.12.3","volume":"63","author":"G Butt","year":"2017","unstructured":"Butt G, Attar R, Tabassum S, Aras A, Qadir MI, Ozbey U, et al. Regulation of signal transduction cascades by Pterostilbenes in different cancers: is it a death knell for oncogenic pathways. Cell Mol Biol. 2017;63(12):5\u201310.","journal-title":"Cell Mol Biol"},{"issue":"1","key":"3013_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010287","volume":"19","author":"RJ Chen","year":"2018","unstructured":"Chen RJ, Kuo HC, Cheng LH, Lee YH, Chang WT, Wang BJ, et al. Apoptotic and nonapoptotic activities of pterostilbene against cancer. Int J Mol Sci. 2018;19(1): 287.","journal-title":"Int J Mol Sci"},{"key":"3013_CR16","first-page":"48","volume-title":"Pterostilbene as a potent chemopreventive agent in cancer. Natural products for cancer chemoprevention: single compounds and combinations","author":"A Levenson","year":"2020","unstructured":"Levenson A, Kumar A. Pterostilbene as a potent chemopreventive agent in cancer. Natural products for cancer chemoprevention: single compounds and combinations. Cham: Springer; 2020. p. 48\u2013108."},{"issue":"10","key":"3013_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/aps.2017.60","volume":"38","author":"YL Wang","year":"2017","unstructured":"Wang YL, Shen Y, Xu JP, Han K, Zhou Y, Yang S, et al. Pterostilbene suppresses human endometrial cancer cells in vitro by down-regulating MIR-663b. Acta Pharmacol Sin. 2017;38(10):1394\u2013400.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"3013_CR18","doi-asserted-by":"publisher","first-page":"11468","DOI":"10.1038\/s41598-023-38692-8","volume":"13","author":"A Go\u0142\u0105bek-Grenda","year":"2023","unstructured":"Go\u0142\u0105bek-Grenda A, Kaczmarek M, Juzwa W, Olejnik A. Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways. Sci Rep. 2023;13(1):11468.","journal-title":"Sci Rep"},{"issue":"2","key":"3013_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/nu10020243","volume":"10","author":"K Chatterjee","year":"2018","unstructured":"Chatterjee K, AlSharif D, Mazza C, Syar P, Sharif MA, Fata JE. Resveratrol and pterostilbene exhibit anticancer properties involving the downregulation of HPV oncoprotein E6 in cervical cancer cells. Nutrients. 2018;10(2): 243.","journal-title":"Nutrients"},{"issue":"5","key":"3013_CR20","first-page":"1384","volume":"23","author":"WH Bin","year":"2018","unstructured":"Bin WH, Da LH, Xue Y, Jing BW. Pterostilbene (3\u2019,5\u2019-dimethoxy-resveratrol) exerts potent antitumor effects in HeLa human cervical cancer cells via disruption of mitochondrial membrane potential, apoptosis induction and targeting m-TOR\/PI3K\/Akt signalling pathway. J BUON. 2018;23(5):1384\u20139.","journal-title":"J BUON"},{"issue":"1","key":"3013_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/molecules25010228","volume":"25","author":"HJ Shin","year":"2020","unstructured":"Shin HJ, Han JM, Choi YS, Jung HJ. Pterostilbene suppresses both cancer cells and cancer stem-like cells in cervical cancer with superior bioavailability to resveratrol. Molecules. 2020;25(1):228.","journal-title":"Molecules"},{"key":"3013_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111058","volume":"396","author":"X Li","year":"2024","unstructured":"Li X, Yu D, Wang Q, Chen Y, Jiang H. Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach. Chem Biol Interact. 2024;396: 111058.","journal-title":"Chem Biol Interact"},{"key":"3013_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fonc.2019.00352","volume":"9","author":"K Chatterjee","year":"2019","unstructured":"Chatterjee K, Mukherjee S, Vanmanen J, Banerjee P, Fata JE. Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis. Front Oncol. 2019;9:352.","journal-title":"Front Oncol"},{"issue":"1","key":"3013_CR24","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1038\/s41598-017-12922-2","volume":"7","author":"W Wen","year":"2017","unstructured":"Wen W, Lowe G, Roberts CM, Finlay J, Han ES, Glackin CA, et al. Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer. Sci Rep. 2017;7(1):12754.","journal-title":"Sci Rep"},{"key":"3013_CR25","doi-asserted-by":"publisher","first-page":"e17601","DOI":"10.1200\/JCO.2024.42.16_suppl.e17601","volume":"42","author":"TH Dellinger","year":"2024","unstructured":"Dellinger TH, Wu X, Cho H, Yost SE, Ruel NH, Invernizzi M, et al. Differential gene expression analysis of a phase II randomized clinical trial of patients with endometrial cancer (EC) treated with megestrol acetate \u00b1 pterostilbene. J Clin Oncol. 2024;42:e17601\u2013e17601.","journal-title":"J Clin Oncol"},{"key":"3013_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/antiox14030345","volume":"14","author":"RN Senguttuvan","year":"2025","unstructured":"Senguttuvan RN, Cho H, Wu X, Frankel PH, Ruel N, Yost SE, et al. The anti-cancer role of pterostilbene in endometrial cancer: a phase II prospective, randomized, window-of-opportunity clinical trial with megestrol acetate. Antioxidants. 2025;14:345.","journal-title":"Antioxidants"},{"issue":"2","key":"3013_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.113933","volume":"435","author":"Z Li","year":"2024","unstructured":"Li Z, Zhang J, You S, Zhang J, Zhang Y, Akram Z, et al. Pterostilbene upregulates MICA\/B via the PI3K\/AKT signaling pathway to enhance the capability of natural killer cells to kill cervical cancer cells. Exp Cell Res. 2024;435(2): 113933.","journal-title":"Exp Cell Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03013-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:16:38Z","timestamp":1758093398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03013-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3013"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03013-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"466"}}